DESOXIMETASONE 0.05% / NIACINAMIDE 4%- desoximetasone 0.05% / niacinamide 4% ointment 
Sincerus Florida, LLC

Disclaimer: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. For further information about unapproved drugs, click here.

----------

DESOXIMETASONE 0.05% / NIACINAMIDE 4%

Directions for use

asd

Sincerus Florida, LLC. Adverse reactions

dx

Active, inactive

zc

NDC 72934- 5069-2 DESOXIMETASONE USP 0.05% / NIACINAMIDE USP 4%. Ointment 30 gm.

s

DESOXIMETASONE 0.05% / NIACINAMIDE 4% 
desoximetasone 0.05% / niacinamide 4% ointment
Product Information
Product TypeHUMAN PRESCRIPTION DRUGItem Code (Source)NDC:72934-5069
Route of AdministrationTOPICAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
NIACINAMIDE (UNII: 25X51I8RD4) (NIACINAMIDE - UNII:25X51I8RD4) NIACINAMIDE4 g  in 100 g
DESOXIMETASONE (UNII: 4E07GXB7AU) (DESOXIMETASONE - UNII:4E07GXB7AU) DESOXIMETASONE0.05 g  in 100 g
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:72934-5069-230 g in 1 BOTTLE, PUMP; Type 0: Not a Combination Product05/22/2019
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
unapproved drug other05/22/2019
Labeler - Sincerus Florida, LLC (080105003)
Establishment
NameAddressID/FEIBusiness Operations
Sincerus Florida, LLC080105003manufacture(72934-5069)

Revised: 5/2019
Document Id: 89804cbd-4ace-9241-e053-2995a90a8a24
Set id: 89804cbd-4acd-9241-e053-2995a90a8a24
Version: 1
Effective Time: 20190522
 
Sincerus Florida, LLC